Security
LNTH · Lantheus Holdings, Inc.
LNTHNASDAQCommon stockCurrentCIK 1521036Updated Sep 26, 2026
Name history
Lantheus MI Holdings, Inc. · through May 23, 2014
LNTH price & chart
Loading TradingView…
NASDAQ:LNTH on TradingView ↗About the company
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Switzerland, Sweden and the United Kingdom, Lantheus has been providing radiopharmaceutical solutions for 70 years. For more information, visit www.lantheus.com.
In the news
Shareholder Alert: Ademi LLP investigates whether Lantheus Holdings, Inc. is obtaining a Fair Price for Public Shareholders ↗
Curium Announces Definitive Agreement to Merge with Lantheus ↗
Shareholders that lost money on Lantheus Holdings, Inc.(LNTH) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More News provided by Levi & Korsinsky, LLP Nov 07, 2025, 16:00 ET Share this article Share to X Share this article Share to X NEW YORK , Nov. 7, 2025 /PRNewswire/ -- Levi & K ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 2,227,399,000Source | 1,980,340,000Source | 1,651,149,000Source | 1,321,258,000Source |
| Property, Plant and Equipment, NetUSD | 163,686,000Source | 176,798,000Source | 146,697,000Source | 122,166,000Source |
| GoodwillUSD | 239,517,000Source | 61,189,000Source | 61,189,000Source | 61,189,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 722,779,000Source | 161,761,000Source | 151,985,000Source | 315,285,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 359,121,000Source | 912,814,000Source | 713,656,000Source | 415,652,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 358,640,000Source | 321,258,000Source | 284,292,000Source | 213,397,000Source |
| Inventory, NetUSD | 64,674,000Source | 68,025,000Source | 64,029,000Source | 35,475,000Source |
| Assets, CurrentUSD | 899,964,000Source | 1,326,633,000Source | 1,085,819,000Source | 677,616,000Source |
| Operating Lease, Right-of-Use AssetUSD | 30,975,000Source | 36,083,000Source | 45,325,000Source | 19,033,000Source |
| Other Assets, NoncurrentUSD | 50,044,000Source | 44,237,000Source | 55,261,000Source | 34,355,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 1,137,602,000Source | 892,329,000Source | 835,257,000Source | 874,111,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 718,000Source | 709,000Source | 699,000Source | 689,000Source |
| Retained Earnings (Accumulated Deficit)USD | 679,504,000Source | 445,945,000Source | 133,503,000Source | -193,158,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -1,307,000Source | -1,615,000Source | -1,037,000Source | -1,259,000Source |
| Stockholders' Equity Attributable to ParentUSD | 1,089,797,000Source | 1,088,011,000Source | 815,892,000Source | 447,147,000Source |
| Additional Paid in Capital, Common StockUSD | 888,320,000Source | 817,972,000Source | 757,727,000Source | 715,875,000Source |
| Liabilities and EquityUSD | 2,227,399,000Source | 1,980,340,000Source | 1,651,149,000Source | 1,321,258,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 333,419,000Source | 240,526,000Source | 187,350,000Source | 247,701,000Source |
| Operating Lease, Liability, CurrentUSD | 3,804,000Source | 1,867,000Source | 1,904,000Source | 2,177,000Source |
| Accounts Payable, CurrentUSD | 42,906,000Source | 34,560,000Source | 41,189,000Source | 20,563,000Source |
| Operating Lease, Liability, NoncurrentUSD | 50,016,000Source | 53,185,000Source | 54,453,000Source | 25,442,000Source |
| Deferred Income Tax Liabilities, NetUSD | 54,246,000Source | — | — | — |
| Other Liabilities, NoncurrentUSD | 107,866,000Source | 63,180,000Source | 63,321,000Source | 46,155,000Source |
| Additional Financial Items | ||||
| Long-term Debt, Excluding Current Maturities | — | — | — | — |
| Long-term Debt, Current MaturitiesUSD | 738,000Source | 974,000Source | 823,000Source | 354,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | — | 557,712,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 85,563,000Source | 76,393,000Source | 50,507,000Source | 29,262,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 17,888,000Source | 37,685,000Source | 68,637,000Source | 128,460,000Source |
| Increase (Decrease) in InventoriesUSD | 9,366,000Source | 2,670,000Source | 36,220,000Source | 7,508,000Source |
| Increase (Decrease) in Accounts PayableUSD | -2,492,000Source | -8,804,000Source | 17,189,000Source | 301,000Source |
| Deferred Income Tax Expense (Benefit)USD | 21,595,000Source | -30,029,000Source | -55,632,000Source | -48,016,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 390,141,000Source | 544,750,000Source | 305,260,000Source | 281,781,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -627,168,000Source | -226,015,000Source | 5,939,000Source | -276,547,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 26,338,000Source | 22,615,000Source | 14,394,000Source | 7,759,000Source |
| Payments for Repurchase of Common StockUSD | 300,017,000Source | 100,000,000Source | 0Source | 75,000,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -316,584,000Source | -118,536,000Source | -13,062,000Source | 311,691,000Source |
| Repayments of Long-term DebtUSD | 1,110,000Source | 318,000Source | 717,000Source | 175,385,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -553,660,000Source | 199,201,000Source | 298,044,000Source | 316,590,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 360,826,000Source | 914,486,000Source | 715,285,000Source | 417,241,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 15,094,000Source | 15,094,000Source | 15,387,000Source | 5,064,000Source |
| Income Taxes Paid, NetUSD | 69,037,000Source | 153,815,000Source | 151,579,000Source | 54,049,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | -49,000Source | -998,000Source | -93,000Source | -335,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 85,563,000Source | 76,393,000Source | 50,507,000Source | 29,262,000Source |
| Amortization of Debt Issuance CostsUSD | 4,457,000Source | 4,296,000Source | 4,300,000Source | 1,249,000Source |
| Amortization of Intangible AssetsUSD | 47,100,000Source | 43,800,000Source | 46,400,000Source | 33,200,000Source |
| Asset Retirement Obligation, Accretion ExpenseUSD | 494,000Source | 428,000Source | 373,000Source | 1,430,000Source |
| Depreciation, Amortization and Accretion, NetUSD | 70,098,000Source | 64,624,000Source | 60,043,000Source | 47,929,000Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | 0Source | 0Source | 5,494,000Source |
| Equity Securities, FV-NI, Gain (Loss)USD | -8,617,000Source | -43,564,000Source | — | — |
| Equity Securities, FV-NI, Unrealized Gain (Loss)USD | -8,617,000Source | -43,564,000Source | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -1,006,000Source | -733,000Source | -21,000Source | -256,000Source |
| Gain (Loss) on Disposition of AssetsUSD | 0Source | 8,415,000Source | 51,789,000Source | 0Source |
| Gain (Loss) on Disposition of Intangible AssetsUSD | 5,000,000Source | — | — | — |
| Gain (Loss) on Disposition of Other AssetsUSD | 0Source | 8,415,000Source | 0Source | 0Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | 0Source | 0Source | 5,494,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | 0Source | 0Source | -588,000Source |
| General and Administrative ExpenseUSD | 275,121,000Source | 193,689,000Source | 125,458,000Source | 133,584,000Source |
| GoodwillUSD | 239,517,000Source | 61,189,000Source | 61,189,000Source | 61,189,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | 80,233,000Source | 118,535,000Source | 84,282,000Source | -1,348,000Source |
| InterestExpenseNonoperatingUSD | 19,749,000Source | 19,669,000Source | — | — |
| Inventory Write-downUSD | 2,202,000Source | -904,000Source | 7,914,000Source | 7,145,000Source |
| Investment Income, InterestUSD | — | 36,838,000Source | 19,638,000Source | 2,613,000Source |
| Net Income (Loss) Attributable to ParentUSD | 233,559,000Source | 312,442,000Source | 326,661,000Source | 28,067,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 233,559,000Source | 312,442,000Source | 326,661,000Source | — |
| Other Nonoperating Income (Expense)USD | 31,326,000Source | 37,231,000Source | 66,320,000Source | -1,703,000Source |
| Proceeds from Issuance of Common StockUSD | — | 3,450,000Source | 1,933,000Source | 1,375,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | 0Source | 0Source | 557,750,000Source |
| Proceeds from Stock Options ExercisedUSD | 7,154,000Source | 3,278,000Source | 3,816,000Source | 7,537,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 1,541,609,000Source | 1,533,910,000Source | 1,296,429,000Source | 935,061,000Source |
| Cost of RevenueUSD | 599,657,000Source | 545,619,000Source | 586,886,000Source | 353,358,000Source |
| Operating Income (Loss)USD | 310,832,000Source | 456,979,000Source | 364,642,000Source | 36,195,000Source |
| Other Nonoperating Income (Expense)USD | 31,326,000Source | 37,231,000Source | 66,320,000Source | -1,703,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 313,792,000Source | 430,977,000Source | 410,943,000Source | 26,719,000Source |
| Income Tax Expense (Benefit)USD | 80,233,000Source | 118,535,000Source | 84,282,000Source | -1,348,000Source |
| Net Income (Loss) Attributable to ParentUSD | 233,559,000Source | 312,442,000Source | 326,661,000Source | 28,067,000Source |
| Earnings Per Share, BasicUSD per share | 3.46Source | 4.52Source | 4.79Source | 0.41Source |
| Earnings Per Share, DilutedUSD per share | 3.41Source | 4.36Source | 4.65Source | 0.4Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 67,489,000Source | 69,199,000Source | 68,266,000Source | 68,487,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 68,443,000Source | 71,651,000Source | 70,239,000Source | 70,671,000Source |
| Interest Expense (non-operating)USD | 19,749,000Source | 19,669,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 47,100,000Source | 43,800,000Source | 46,400,000Source | 33,200,000Source |
| Current Income Tax Expense (Benefit)USD | 58,638,000Source | 148,564,000Source | 139,914,000Source | 46,668,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -1,006,000Source | -733,000Source | -21,000Source | -256,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | 0Source | 0Source | 5,494,000Source |
| General and Administrative ExpenseUSD | 275,121,000Source | 193,689,000Source | 125,458,000Source | 133,584,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | 0Source |
| Gross ProfitUSD | 941,952,000Source | 988,291,000Source | 709,543,000Source | 581,703,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 320,265,000Source | 429,899,000Source | 410,326,000Source | 29,012,000Source |
| Interest ExpenseUSD | — | — | 20,019,000Source | 7,185,000Source |
| Interest Income, OtherUSD | 23,391,000Source | — | — | — |
| Investment Income, InterestUSD | — | 36,838,000Source | 19,638,000Source | 2,613,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 233,559,000Source | 312,442,000Source | 326,661,000Source | — |
| Research and Development ExpenseUSD | 177,308,000Source | 168,098,000Source | 77,707,000Source | 311,681,000Source |
| Selling and Marketing ExpenseUSD | 178,691,000Source | 177,940,000Source | 141,736,000Source | 100,243,000Source |
Filing attachments
lnth-ex99_1.htm · 8-K · 2026-08-06
EX-99.1 2 lnth-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Lantheus Reports Second Quarter 2026 Financial Results • Worldwide revenue of $388.2 million in the second quarter of 2026 • GAAP fully diluted earnings per share of $1.11, compared to $1.12 in the second quarter of 2025 • Adjusted fully diluted earnings per share of $1.55, compared to $1.57 in the second quarter of 2025 • Announced on August 3, 2026 that it has entered into a definitive agreement to merge with Curium under which C…
Read attachment ↗d148563dex991.htm · 8-K · 2026-08-03
EX-99.1 2 d148563dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Curium Announces Definitive Agreement to Merge with Lantheus Strategic transaction would bring Curium’s theranostics portfolio and global manufacturing platform together with Lantheus’ complementary U.S. radiodiagnostics business Total transaction consideration to Lantheus shareholders of up to $114.50 per share in cash for an aggregate transaction value of up to $8.0 billion – representing a premium of 38% to Lantheus’ una…
Read attachment ↗d148563dex992.htm · 8-K · 2026-08-03
EX-99.2 3 d148563dex992.htm EX-99.2 EX-99.2 Exhibit 99.2 Lantheus Announces Definitive Agreement to Merge with Curium Combined company would span full radiopharmaceutical value chain delivering nuclear medicine solutions to patients and healthcare systems across more than 70 countries August 3, 2026 © 2026 Lantheus. All rights reserved. Safe Harbor Statements Additional Information and Where to Find it In connection with the proposed acquisition of Lantheus Holdings, Inc. (the “Company”) b…
Read attachment ↗lnth-ex99_1.htm · 8-K · 2026-05-07
EX-99.1 2 lnth-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Lantheus Reports First Quarter 2026 Financial Results and Provides Business Update • Strong start to the year with worldwide revenue of $377.3 million in the first quarter 2026 • GAAP fully diluted earnings per share of $1.80, compared to $1.02 in the first quarter of 2025 • Adjusted fully diluted earnings per share of $1.46, compared to $1.53 in the first quarter of 2025 • FDA approves PYLARIFY TruVuTM (piflufolastat F18); phased …
Read attachment ↗lnth-ex99_1.htm · 8-K · 2026-02-26
EX-99.1 2 lnth-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update • Worldwide revenue of $406.8 million and $1.54 billion for the fourth quarter and full year 2025 • GAAP fully diluted earnings per share of $0.82 and $3.41 for the fourth quarter and full year 2025 • Adjusted fully diluted earnings per share of $1.67 and $6.08 for the fourth quarter and full year 2025 • Repurchased $100 million of sha…
Read attachment ↗lnth-ex99_1.htm · 8-K · 2025-11-06
EX-99.1 2 lnth-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update • Recorded third quarter 2025 worldwide revenue of $384.0 million, GAAP fully diluted earnings per share of $0.41, adjusted fully diluted earnings per share of $1.27 and free cash flow of $94.7 million • Separately announced upcoming retirement of CEO, departure of President and appointment of prior CEO to Executive Chairperson; Board conducting CEO se…
Read attachment ↗